Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000486604 | SCV000571300 | uncertain significance | not provided | 2018-05-08 | criteria provided, single submitter | clinical testing | This variant is denoted POLD1 c.2717+9C>A or IVS21+9C>A and consists of a C>A nucleotide substitution at the +9 position of intron 21 of the POLD1 gene. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. POLD1 c.2717+9C>A was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The cytosine (C) nucleotide that is altered is not conserved across species. In silico models are inconclusive with respect to splicing, and in the absence of RNA or functional studies, the actual effect of this variant is unknown. Based on currently available information, it is unclear whether POLD1 c.2717+9C>A is pathogenic or benign. We consider it to be a variant of uncertain significance. |
Invitae | RCV001088385 | SCV000767720 | likely benign | Colorectal cancer, susceptibility to, 10 | 2024-01-18 | criteria provided, single submitter | clinical testing |